Beam Therapeutics to Participate in 2025 RBC Capital Markets Global Healthcare Conference

Company Overview - Beam Therapeutics Inc. is a biotechnology company focused on developing precision genetic medicines through base editing [3] - The company aims to establish a leading, fully integrated platform for precision genetic medicines, incorporating gene editing, delivery, and internal manufacturing capabilities [3] - Beam's proprietary technology, base editing, allows for precise and efficient single base changes in targeted genomic sequences without causing double-stranded breaks in DNA [3] Upcoming Events - Management will participate in a fireside chat at the 2025 RBC Capital Markets Global Healthcare Conference on May 20, 2025, at 11:00 a.m. ET in New York [1] - The live webcast of the event will be available on the company's investor section of the website and archived for 60 days post-presentation [2] Commitment and Vision - Beam Therapeutics is a values-driven organization dedicated to its people and cutting-edge science [3] - The company envisions providing life-long cures to patients suffering from serious diseases through its diversified portfolio of base editing programs [3]